Mammotome SCM23
by Devicor Medical Products, Inc.
Mammotome SCM23 is a mammographic stereotactic biopsy system (FDA Class II; FDA product code KNW, Instrument, Biopsy) made by Devicor Medical Products, Inc., cleared under FDA 510(k) K042753 on 8 Nov 2004 and listed in FDA GUDID since 10 Nov 2016 (UDI-DI 00841911100607), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00841911100607 | Date10 Nov 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK042753 | Date8 Nov 2004 | StatusActive |
Official records
- AccessGUDID record 00841911100607
- FDA 510(k) database K042753
From the FDA record
- Device description
- Control Module with SmartVac
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K042753 decided 8 Nov 2004 Active
- FDA GUDID UDI-DI 00841911100607 listed 10 Nov 2016 Listed
Timeline
- Cleared FDA 510(k) K042753
- Listed FDA GUDID 00841911100607
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Mammotome
- Generic name
- Mammographic stereotactic biopsy system
- Model / Ref / Catalog
- SCM23
- Primary DI / UDI-DI
- 00841911100607
- 510(k) Number
- FDA product code
- KNW
- GMDN term
- Mammographic stereotactic biopsy system
- Device class
- Class II
- Regulation number
- 876.1075
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Mammographic stereotactic biopsy system.